Business Segments Legend Biotech Corporation
Equities
LEGN
US52490G1022
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.92 USD | -0.62% |
|
+32.69% | +14.08% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Biological Products | |||||||||
Biotechnology | 91.56M | 117M | 285M | 627M | 1.03B | ||||
Total Assets | 1.12B | 1.33B | 1.85B | 1.67B | 1.73B | ||||
Interest Expense | -900K | -10.8M | -21.79M | -21.62M | -21.4M | ||||
Income Tax Expense | 1K | 625K | -1.86M | 18.89M | 14.2M | ||||
CAPEX | -47.11M | -22.28M | -20.08M | -14.1M | -28.6M | ||||
EBT | -386M | -446M | -520M | -158M | -283M | ||||
D&A | 12.54M | 15.92M | 18.53M | 21.59M | 28.9M | ||||
Operating Income | - | - | - | - | -136M | ||||
Net Income | -386M | -446M | -518M | -177M | -297M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
United States of America | 86.37M | 117M | 270M | 579M | 804M | ||||
Total Assets | 104M | 114M | 151M | 188M | 318M | ||||
outside The United States of America | - | - | - | - | 199M | ||||
China | 3.42M | 328K | 179K | 320K | 26.6M | ||||
Total Assets | 50.8M | 54.51M | 56.01M | 46.08M | 44.7M | ||||
Europe | - | - | 15.07M | 47.87M | - | ||||
Total Assets | - | - | 139M | 147M | 119M | ||||
North America | - | - | - | - | - | ||||
Other | - | 75K | - | - | - | ||||
Total Assets | 10.46M | 62.91M | - | - | - |
- Stock Market
- Equities
- LEGN Stock
- Financials Legend Biotech Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition